Sovereign Pharmaceuticals Becomes First Manufacturer to Earn All GS1 EPCIS Trustmarks for FDA DSCSA Interoperability Mandate
Drummond Group & Vantage Consulting Key Partners in Sovereign’s Implementation of Drummond Certified™ QU4RTET Track and Trace Solution
This content was submitted directly to this website by the supplier.
Mar 8th, 2021
Drummond Group LLC, provider software compliance and interoperability testing, announced validation of Sovereign Pharmaceuticals’ implementation for compliance to all seven GS1 US Rx Electronic Product Code Information Services (EPCIS) Conformance Testing scenarios for manufacturers.
With Vantage Consulting Group’s guidance as a key partner, Sovereign utilized QU4RTET 3.0 to meet the requirements of the Drug Supply Chain Security Act (DSCSA) that ensures the FDA and law enforcement agencies may securely detect stolen, contaminated or counterfeit drugs. In 2020, Vantage first completed Drummond EPCIS Cerification testing of QU4R
Sovereign Pharmaceuticals Becomes First Manufacturer to Earn All GS1 EPCIS Trustmarks for FDA DSCSA Interoperability Mandate
Share Article
Drummond Group & Vantage Consulting Key Partners in Sovereign’s Implementation of Drummond Certified™ QU4RTET Track and Trace Solution
“Successfully passing all seven GS1 EPCIS Conformance Testing scenarios is a major accomplishment. Drummond commends Sovereign and Vantage on this partnership and success.” PORTSMOUTH, N.H. (PRWEB) February 25, 2021
Drummond Group LLC, a trusted leader in software compliance and interoperability testing, today announced validation of Sovereign Pharmaceuticals’ implementation for compliance to all seven GS1 US Rx Electronic Product Code Information Services (EPCIS) Conformance Testing scenarios for manufacturers. With Vantage Consulting Group’s guidance as a key partner, Sovereign utilized QU4RTET 3.0 to meet the requirements of the